Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
BUSINESS
Public Knowledge-Based Application Filed for Tamiflu’s New Pediatric Dosage
Chugai Pharmaceutical said on December 16 that it has filed a public knowledge-based application for a new pediatric dosage of its anti-influenza drug Tamiflu Dry Syrup 3% (oseltamivir). The new dosage was filed for the treatment, and not prevention, of…
To read the full story
Related Article
- MHLW Panel OKs Celgene’s Apremilast, 2 Other NMEs
November 25, 2016
- Council OKs Public Knowledge-Based Application for Tamiflu’s New Pediatric Dosage
November 22, 2016
BUSINESS
- Nipro Eyes 50-60 Stemirac Treatment Sites across Japan after Full Nod
November 20, 2026
- AstraZeneca’s Etcamah to Hit Japan Market on Nov. 27
November 20, 2026
- Japan Drug Makers’ Sales Seen Dipping in FY2026 on Co-Marketing Exits
November 20, 2026
- J&J’s Icotyde Could Broaden Psoriasis Treatment Options: Expert
November 20, 2026
- Nippon Kayaku to Acquire AstraZeneca’s Zoladex on Dec. 16
November 20, 2026





